Insulet Corp (PODD)
164.73
-1.53
(-0.92%)
USD |
NASDAQ |
Apr 18, 16:00
164.66
-0.07
(-0.04%)
Pre-Market: 20:00
Insulet Revenue (TTM): 1.697B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.697B |
| September 30, 2023 | 1.557B |
| June 30, 2023 | 1.465B |
| March 31, 2023 | 1.368B |
| December 31, 2022 | 1.305B |
| September 30, 2022 | 1.243B |
| June 30, 2022 | 1.178B |
| March 31, 2022 | 1.142B |
| December 31, 2021 | 1.099B |
| September 30, 2021 | 1.037B |
| June 30, 2021 | 995.60M |
| March 31, 2021 | 958.70M |
| December 31, 2020 | 904.40M |
| September 30, 2020 | 867.70M |
| June 30, 2020 | 825.80M |
| March 31, 2020 | 776.60M |
| December 31, 2019 | 738.20M |
| September 30, 2019 | 693.68M |
| June 30, 2019 | 652.66M |
| March 31, 2019 | 599.82M |
| December 31, 2018 | 563.80M |
| September 30, 2018 | 529.47M |
| June 30, 2018 | 500.17M |
| March 31, 2018 | 485.66M |
| December 31, 2017 | 463.80M |
| Date | Value |
|---|---|
| September 30, 2017 | 436.82M |
| June 30, 2017 | 409.92M |
| March 31, 2017 | 387.49M |
| December 31, 2016 | 366.99M |
| September 30, 2016 | 347.22M |
| June 30, 2016 | 323.74M |
| March 31, 2016 | 296.96M |
| December 31, 2015 | 263.89M |
| September 30, 2015 | 195.25M |
| June 30, 2015 | 198.85M |
| March 31, 2015 | 210.31M |
| December 31, 2014 | 231.32M |
| September 30, 2014 | 284.69M |
| June 30, 2014 | 270.81M |
| March 31, 2014 | 258.89M |
| December 31, 2013 | 247.08M |
| September 30, 2013 | 236.38M |
| June 30, 2013 | 230.03M |
| March 31, 2013 | 220.97M |
| December 31, 2012 | 211.37M |
| September 30, 2012 | 200.73M |
| June 30, 2012 | 190.58M |
| March 31, 2012 | 171.75M |
| December 31, 2011 | 152.26M |
| September 30, 2011 | 132.83M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
652.66M
Minimum
Jun 2019
1.697B
Maximum
Dec 2023
1.079B
Average
1.037B
Median
Sep 2021
Revenue (TTM) Benchmarks
| Abbott Laboratories | 40.11B |
| Stryker Corp | 20.50B |
| Becton Dickinson & Co | 19.49B |
| Haemonetics Corp | 1.270B |
| Tandem Diabetes Care Inc | 747.72M |